| Maria Rafanan Prince, MD | |
|
7745 Tilghman St, Fulton, MD 20759-2547 | |
| (443) 745-4795 | |
| Not Available |
| Full Name | Maria Rafanan Prince |
|---|---|
| Gender | Female |
| Speciality | Preventive Medicine - Public Health & General Preventive Medicine |
| Location | 7745 Tilghman St, Fulton, Maryland |
| Accepts Medicare Assignments | Does not participate in Medicare Program. She may not accept medicare assignment. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1902659154 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2083P0901X | Preventive Medicine - Public Health & General Preventive Medicine | D65012 (Maryland) | Primary |
| Mailing Address | Practice Location Address |
|---|---|
| Maria Rafanan Prince, MD 7745 Tilghman St, Fulton, MD 20759-2547 Ph: (443) 745-4795 | Maria Rafanan Prince, MD 7745 Tilghman St, Fulton, MD 20759-2547 Ph: (443) 745-4795 |
News Archive
Teva Pharmaceutical Industries Ltd. Has won U.S. approval to sell the first generic version of Lexapro for depression and anxiety. Teva has been granted a 180-day exclusivity, so no other firm can market the generic medication in the United States in that timeframe, the Food and Drug Administration (FDA) said in a news release.
RESEARCH-active members of the public are to showcase how their vital work helps shape clinical research projects and improves care for patients at a free drop-in event in Sheffield City Centre on Wednesday 22 April.
The discovery by Australian Scientists of a gene that appears to be linked to blood vessel growth in tumours in mice, may one day lead to better treatments for cancer in people.
People at risk for a certain form of colon and other types of cancer may soon have a better chance at surviving or even avoiding the diseases, thanks to a new study done by the Intermountain Clinical Genetics Institute at LDS Hospital.
› Verified 5 days ago